ELMD
Electromed Inc
$
19.730
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
19.940
Open
19.540
VWAP
19.72
Vol
33.02K
Mkt Cap
165.46M
Low
19.540
Amount
651.38K
EV/EBITDA(TTM)
15.11
Total Shares
8.66M
EV
150.22M
EV/OCF(TTM)
12.49
P/S(TTM)
2.88
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
17.52M
+7.79%
--
--
16.34M
+11.4%
--
--
16.51M
+11.29%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Electromed, Inc. (ELMD) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 2.02%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+2.02%
In Past 3 Month
3 Analyst Rating
58.79% Upside
Wall Street analysts forecast ELMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELMD is 31.33 USD with a low forecast of 29.00 USD and a high forecast of 36.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
58.79% Upside
Current: 19.730
Low
29.00
Averages
31.33
High
36.00
58.79% Upside
Current: 19.730
Low
29.00
Averages
31.33
High
36.00
Roth Capital
initiated
$29
2025-07-21
Reason
Roth Capital
Price Target
$29
2025-07-21
initiated
Reason
Roth Capital initiated coverage of Electromed with a Buy rating and $29 price target. The company, which is focused on developing, manufacturing, and marketing noninvasive airway clearance therapy devices, is taking share by \"offering a better technology with a pure-play focus and expanding the market with new clinical evidence and physician education,\" the analyst tells investors. The firm believes the company can continue to post double-digit revenue growth with \"meaningful operating leverage,\" the analyst added.
B. Riley Securities
Kyle Bauser
Strong Buy
Initiates
$38
2025-02-20
Reason
B. Riley Securities
Kyle Bauser
Price Target
$38
2025-02-20
Initiates
Strong Buy
Reason
B. Riley analyst Kyle Bauser initiated coverage of Electromed with a Buy rating and $38 price target. Electromed is a profitable, growing medical device company that manufactures and sells high-frequency chest wall oscillation airway clearance products for patients with chronic respiratory conditions, the analyst tells investors in a research note. The firm believes the company can reach $1.00 per share of earnings by fiscal 2026 and reach 20% operating margins over time. Electromed is also an attractive takeout target for a larger medical technology strategy looking to leverage the pulmonologist call point, contends B. Riley.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Electromed Inc (ELMD.A) is 20.80, compared to its 5-year average forward P/E of 30.84. For a more detailed relative valuation and DCF analysis to assess Electromed Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
30.84
Current PE
20.80
Overvalued PE
39.54
Undervalued PE
22.14
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
16.94
Current EV/EBITDA
9.71
Overvalued EV/EBITDA
22.71
Undervalued EV/EBITDA
11.17
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
2.35
Current PS
2.37
Overvalued PS
2.97
Undervalued PS
1.73
Financials
Annual
Quarterly
FY2025Q3
YoY :
+13.07%
15.68M
Total Revenue
FY2025Q3
YoY :
+16.24%
2.14M
Operating Profit
FY2025Q3
YoY :
+26.66%
1.89M
Net Income after Tax
FY2025Q3
YoY :
+23.53%
0.21
EPS - Diluted
FY2025Q3
YoY :
+69.15%
2.07M
Free Cash Flow
FY2025Q3
YoY :
+4.17%
77.97
Gross Profit Margin - %
FY2025Q3
YoY :
+115.08%
19.25
FCF Margin - %
FY2025Q3
YoY :
+12.08%
12.06
Net Margin - %
FY2025Q3
YoY :
+50.14%
16.56
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
8.5M
USD
11
0-12
Months
4.2M
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
8.5M
USD
11
0-12
Months
4.2M
USD
3
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ELMD News & Events
Events Timeline
2025-05-27 (ET)
2025-05-27
16:09:47
Electromed to join Russell 2000 and Russell 3000 Indexes
2025-05-13 (ET)
2025-05-13
16:10:43
Electromed reports Q3 EPS 21c vs 17c last year
2025-03-10 (ET)
2025-03-10
09:02:41
Electromed announces $5M share repurchase authorization
Sign Up For More Events
Sign Up For More Events
News
9.5
08-12NASDAQ.COMClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
1.0
07-29NewsfilterElectromed, Inc. to Participate in the Canaccord Genuity 45th Annual Growth Conference
4.0
07-12NASDAQ.COMValidea Peter Lynch Strategy Daily Upgrade Report - 7/12/2025
Sign Up For More News
People Also Watch
BRBS
Blue Ridge Bankshares Inc
3.790
USD
-0.79%
RZLT
Rezolute Inc
6.470
USD
+4.35%
AQST
Aquestive Therapeutics Inc
4.010
USD
+6.08%
DSGN
Design Therapeutics Inc
5.420
USD
+8.84%
FPH
Five Point Holdings LLC
5.570
USD
+0.54%
AVIR
Atea Pharmaceuticals Inc
3.500
USD
-0.28%
ARQ
Arq Inc
7.730
USD
+7.36%
DOMO
Domo Inc
14.400
USD
-0.93%
RGP
Resources Connection Inc
4.930
USD
+8.35%
SMTI
Sanara Medtech Inc
31.920
USD
+16.20%
FAQ
What is Electromed Inc (ELMD) stock price today?
The current price of ELMD is 19.73 USD — it has increased 2.02 % in the last trading day.
What is Electromed Inc (ELMD)'s business?
What is the price predicton of ELMD Stock?
What is Electromed Inc (ELMD)'s revenue for the last quarter?
What is Electromed Inc (ELMD)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Electromed Inc (ELMD)'s fundamentals?
How many employees does Electromed Inc (ELMD). have?